コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 commercial viability of direct methanol fuel cell technology.
2 basis for the market-leading thin-film solar-cell technology.
3 herapeutic approaches using pluripotent stem cell technology.
4 pening the door for a truly recyclable solar cell technology.
5 n be applied to any multi-dimensional single-cell technology.
6 novel mouse strains via embryonic stem (ES) cell technology.
7 be crucial for medical applications of stem cell technology.
8 mutation at the DMa locus via embryonic stem cell technology.
9 m the endogenous genome using embryonic stem cell technology.
10 r1) gene were generated using embryonic stem cell technology.
11 icient for both genes through embryonic stem cell technology.
12 mutation at the DMa locus via embryonic stem cell technology.
13 -deficient mice through mouse embryonic stem cell technology.
14 deficient in Smad5 using embryonic stem (ES) cell technology.
15 nalyze Smad2 mutant embryos created using ES cell technology.
16 eficient in FKBP12 using embryonic stem (ES) cell technology.
17 H beta subunit and therefore in FSH using ES cell technology.
18 homologous recombination and embryonic stem cell technology.
19 cin have been generated using embryonic stem cell technology.
20 e region were generated using embryonic stem cell technology.
21 essed with LT-alpha using baculovirus/insect cell technology.
22 s involving light-emitting devices and solar cell technology.
23 igh to revolutionize ceramic electrochemical cell technology.
24 te advanced applications in sensing and fuel cell technology.
25 enefit the widespread commercial use of fuel cell technology.
26 r potential as imperative components of fuel cell technology.
27 nformation and is compatible with any single-cell technology.
28 new directions in DNA computing and minimal cell technology.
29 ity of iPS cells is an important goal in iPS cell technology.
30 R) are at the heart of key green-energy fuel cell technology.
31 such as artificial photosynthesis and solar cell technology.
32 he I(-)/I3(-) couple in dye-sensitized solar cell technology.
33 overall efficiency and marketability of fuel cell technology.
34 pave a way for the commercialization of fuel cell technologies.
35 e tissues profiled using a variety of single-cell technologies.
36 quantification using cell-sorting or single-cell technologies.
37 terogeneous data obtained using these single-cell technologies.
38 d disease models that have incorporated stem cell technologies.
39 iciencies comparable to other emerging solar cell technologies.
40 ranslational ramifications for cortical stem cell technologies.
41 ctive AAEMs could significantly advance fuel cell technologies.
42 rovide an alternative to hydrogen-based fuel-cell technologies.
43 kinetics, is urgently needed to advance fuel cell technologies.
44 ain with a particular focus on recent single-cell technologies.
45 gineering biology applications in artificial cell technologies.
46 enting higher throughput with current single-cell technologies.
47 has been a key challenge for advancing fuel cell technologies.
48 ed by the sparse sampling inherent in single cell technologies.
49 eal datasets generated with different single-cell technologies.
50 l that is complementary with existing single-cell technologies.
51 on-processable alternatives to silicon solar cell technologies.
52 has been a key challenge for advancing fuel cell technologies.
53 s low-cost competitor to silicon based solar cell technologies.
54 heterogeneity is a major advantage of single-cell technologies.
56 nered increasing support for the use of fuel-cell technology, a prime example being the solid-oxide f
61 which can be harnessed using microbial fuel-cell technology, allowing both wastewater treatment and
69 gical advances, including new models, single-cell technologies and gene editing, could provide new in
72 der the key challenges posed by various stem cell technologies and liver pathologies for developing c
73 echniques established for dissociated single-cell technologies and thus do not take spatial organizat
76 human PSC clinical trials by Geron, Advanced Cell Technology and the Kobe Center for Developmental Bi
77 ranslational step in the development of stem cell technology and the subject of a report in this issu
78 fluorescent-tags are desirable in basic stem cell technology and therapeutic applications of cells.
79 lular model systems, high-dimensional single-cell technologies, and lineage tracing have sparked a re
80 ssible links between ES-cell and neural stem-cell technologies, and the strategies used to isolate an
81 spinal cord injury, there is no agreement on cell technology, and claims of beneficial results lack i
82 othelial cells, using human pluripotent stem cell technology, and extensively characterized its molec
87 urface markers and the development of single-cell technologies are enabling precise elucidation of ce
90 rays into clinical settings, however, single-cell technologies are not yet routinely used to inform m
95 se oxidation is of great interest in biofuel cell technology because the enzyme are unaffected by the
96 were generated by traditional embryonic stem cell technology, but these animals contain a biased T ce
97 ion of the development of innovation in stem cell technologies by network analysis of stem cell paten
98 eloped a high-throughput, multiplexed single-cell technology called TISCC-seq to engineer predesignat
100 For solid organ transplantation, single-cell technologies can provide in-depth insights into the
101 , which gathered experts to discuss how stem cell technologies can support traditional conservation t
105 aches for reducing the Dmin, e.g., collision cell technology (CCT) and analyte isotope selection, are
108 we emphasize the need for innovative single-cell technologies combined with mathematical models to f
109 that utilized the latest advances in single-cell technology combined with spatial methods to analyze
111 ning public because of the promise that stem cell technology could deliver tissue regeneration for in
115 er intravitreal implantation of encapsulated cell technology (ECT) devices releasing ciliary neurotro
120 advanced analytical methods, such as single-cell technologies, enable unprecedented and deeper under
123 The DARC (Detection of Apoptosing Retinal Cells) technology enables in vivo real-time non-invasive
124 decade has seen dramatic progress in single-cell technologies establishing the diverse phenomena of
125 l m(6)A profiling in bulk sequencing, single-cell technologies for analyzing m(6)A heterogeneity are
127 e RNA vaccine BNT162b2 using multiple single-cell technologies for in depth analysis of longitudinal
132 the development of induced pluripotent stem cell technology for the use of patient-specific iPSCs to
133 omics profiles generated by different single-cell technologies from the same biological sample is sti
134 solation utilizing conditional reprogramming cell technology from mastectomy tissue ipsilateral to in
135 revolutionized by recent advances in single-cell technology, from imaging approaches through to 'omi
136 ed a combination of induced pluripotent stem cell technology, genomics, and molecular biology in this
139 ecade, the advent of multidimensional single-cell technologies has provided the unprecedented ability
149 Recent breakthroughs in pluripotent stem cell technologies have enabled a new class of in vitro s
151 Advances in flow cytometry and other single-cell technologies have enabled high-dimensional, high-th
163 research and the use of cutting-edge single cell technologies have shed new light on the development
174 , fetal intervention, and hematopoietic stem cell technology have removed many of the practical, tech
177 reater challenges, but rapidly emerging stem cell technologies hold the promise of autologous grafts
178 recent development of progenitor and/or stem cell technologies holds promise for the treatment of cur
180 , tissue engineering, aided by emerging stem cell technology, holds immense potential for the treatme
182 gest that CNTF delivered by the encapsulated cell technology implant appears to slow the progression
184 l received CNTF delivered by an encapsulated cell technology implant in one eye and sham surgery in t
187 ies as well as the clinical impact of single-cell technologies in CVD patient care are highlighted, a
197 Review, we describe the current state of iPS cell technology, including approaches by which they are
198 The introduction of liquid microjet and flow cell technologies into XAS experiments has enabled the g
200 dvent of high-throughput/high-content single cell technologies is leading to an explosion in the numb
207 n be incorporated by means of embryonic stem cell technology, little progress has been made toward in
212 R immune responses and discuss how new CAR T cell technologies might impact the risk of immunogenicit
213 vances in cell-sorting techniques and single-cell technologies now make this possible, with the ident
219 extension of the capability to other single-cell technologies or environmental applications with dat
220 review, we highlight advancements in single-cell technologies, outline important shortcomings in our
223 otype, termed induced pluripotent stem (iPS) cell technology, presents an exciting potential venue to
226 , but recent integration of genomic and stem cell technologies promises a route through this impasse.
227 ods routinely build on large screens, single cell technologies, proteomics, and other modalities to i
232 maging and genetics and the advent of single-cell technologies provided new insights into the much mo
233 gy strategies have rapidly entered mammalian cell technology providing novel therapeutic solutions.
236 In this study, we apply multi-modal single-cell technologies: single-cell RNA sequencing, T cell an
238 e emerging lead (Pb) halide perovskite solar cell technology still faces significant challenges, one
239 ardiomyocyte cell cycle and advances in stem cell technology, strategies have evolved that demonstrat
242 nt in this field makes it likely that single-cell technologies such as scRNA-seq will have an impact
246 tool that uses the UTR enrichment of single-cell technologies, such as 10x Chromium, to accurately a
248 s of state-of-the-art and forthcoming single-cell technologies, such as multidimensional mass cytomet
252 ss recent advances in multi-omics and single-cell technologies that enable genes, transcriptional reg
254 measurements and explore advances in single-cell technologies that overcome these problems by expand
255 are no reported T cell receptor-engineered T cell technology that can redirect T cell specificity to
258 reater understanding of the capacity of stem cell technologies, there is growing public hope that ste
260 nductivity along with implementation in fuel cell technology through membrane electrode assembly are
261 m threshold across different species, single-cell technologies, tissues and cell types has not been a
265 hosted a virtual workshop on the topic of T cell technologies to discuss assays, novel technology de
267 t al. (2015) combine gene targeting and stem cell technologies to identify a significant cellular eff
269 ques have been developed that utilize single cell technologies to interrogate a broad range of cell-b
270 amics, and explore the application of single-cell technologies to obtain functional insights into cel
271 nally, we highlight opportunities for single cell technologies to shed light on the causes and conseq
273 he immense potential of this thin-film solar cell technology to become a low-cost alternative to the
274 de new insights regarding antigen-specific T cell technology to benefit a rapidly expanding T cell th
275 the seasonal deficits by using automated red cell technology to collect double red blood cell units;
276 ated Ucn-deficient mice using embryonic stem cell technology to determine its role in stress-induced
277 combination of transgenic and embryonic stem cell technology to generate a mouse line in which the mu
278 n metabolism in vivo, we used embryonic stem cell technology to generate GGT-deficient (GGTm1/GGTm1)
279 d tissue injury in humans include using stem cell technology to generate human cells for screening fo
282 Consortium has used induced pluripotent stem cell technology to study the effects of common genetic v
283 ategies supporting the rapid advance of stem cell technology to the clinic, the philosophies behind t
285 recent advances in the application of single-cell technologies, towards gaining a deeper understandin
286 derlying principles and compromises of CAR T-cell technology using the CD19-targeted CAR as a paradig
287 atial transcriptomics and multiplexed single-cell technologies, we identify that the double negative
292 ular components, and the advent of human iPS cell technology when combined with recent advances in th
293 in combination with induced pluripotent stem cell technology, which enables the derivation of differe
295 tained through studies using advanced single-cell technologies will be crucial to establishing unifie
298 en these cell populations, enabled by single cell technologies, will help to elucidate the events und
299 ly review recent progress using novel single-cell technologies with an emphasis on the TME biology of
300 e demonstrate that the combination of single-cell technologies with computational analysis tools enab